beta-secretase inhibitors (Merck & Co/Sunesis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namebeta-secretase inhibitors (Merck & Co/Sunesis)
Drug Alias NameBACE-1 inhibitors (Merck & Co/Sunesis)Merck-4Merck-3aTC-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-secretase 1 inhibitorsBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 proteinBeta-secretase 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesViracta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViracta Therapeutics IncMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A